Boston Scientific
TriMed Staff | March 24, 2009 | Cardiovascular Business | Patient Care
Boston Scientific (Booth 3243) is featuring several oral contributions and poster presentations, all of which highlight its Taxus paclitaxel drug-eluting stent technology.

Among the presentations are:
  • A plenary session on Saturday, March 28, entitled "Health Related Quality of Life and U.S. Based Economic Outcomes of PCI With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel and Left Main Coronary Artery Disease: 1-Year Results From the SYNTAX Trial"
  • An oral presentation on Saturday, March 28, entitled "Revascularization With Cardiac Surgery Versus Paclitaxel-Eluting Stents in Patients With Diabetes and Metabolic Syndrome: 1-Year Results From the SYNTAX Study"
  • Five poster presentations on Sunday, March 29, entitled "Effect of Gender on One Year Outcomes in the SYNTAX Trial," "The Impact of Age on One Year Outcomes in the SYNTAX Trial," "Randomized Comparison of Everolimus-eluting and Paclitaxel-eluting Stents: Pooled analysis of Two-Year Clinical Follow-up from the SPIRIT II and III Trials," "Paclitaxel-Eluting Stents for the Treatment of Bare Metal Stent Restenosis: Three-Year Results of the TAXUS vs. ISR Trial" and "TAXUS ARRIVE Program: The Utility of a Comprehensive Drug-Eluting Stent Registry."

TriMed Staff

Related Content

Cardiologist moves to Mississippi to fight back against PAD and limit amputations
On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms
Peripheral artery disease is out of control in many rural, low income communities
The many benefits of using low-cost CT coronary calcium scoring to screen patients
Early feasibility study for implantable heart failure monitor moves forward 
Using 'magic' to calm pediatric patients during imaging exams

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup